Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for Zentalis Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ZNTL).
- Disclosed ownership: 1.3%.
- Date of event: 30 Sep 2025.
MILLENNIUM MANAGEMENT LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Zentalis Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ZNTL)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- ZNTL
- Shares outstanding
- 69,424,692 shares
- Disclosed Ownership
- 902,521 shares
- Ownership
- 1.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Oct 2025, 16:00:31 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 04 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 1.3% ownership in Zentalis Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ZNTL) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 04 Feb 2025.
- Current filing was accepted on 14 Oct 2025, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Millennium Management LLC | 1.3% | 902,521 | 0 | 902,521 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 1.3% | 902,521 | 0 | 902,521 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 1.3% | 902,521 | 0 | 902,521 | /s/ Israel A. Englander | Israel A. Englander |